What is the current Price Target for the Vivoryon Therapeutics stock?

The average Vivoryon Therapeutics target price is €6.75. This is 275.84% higher than the current stock price. The highest price target is 373.27%, the lowest is 178.40%. 2 Analysts have issued a price target Vivoryon Therapeutics 2026 .

How high will the Vivoryon Therapeutics stock rise?

No reliable answer can be given as to how high the Vivoryon Therapeutics stock will rise. The performance of stocks, including the Vivoryon Therapeutics stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Vivoryon Therapeutics stock today?

The performance of Vivoryon Therapeutics stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Vivoryon Therapeutics stock fall?

The decline in Vivoryon Therapeutics stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Vivoryon Therapeutics Forecast, price target & analysts

€1.79

0.11% today

Amsterdam, May 21, 01:10 pm CET

ISIN

NL00150002Q7

Symbol

VVY

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts Strategies

Vivoryon Therapeutics Target price 2025 - Analyst rating & recommendation

Vivoryon Therapeutics Classifications & Recommendation:

Buy

100%

Vivoryon Therapeutics Price Target

Target Price	€6.75
Price	€1.80
Potential	275.84% register free of charge
Number of Estimates	2

	2 Analysts have issued a price target Vivoryon Therapeutics 2026 . The average Vivoryon Therapeutics target price is €6.75. This is 275.84% register free of charge higher than the current stock price. The highest price target is €8.50 373.27% register free of charge , the lowest is €5.00 178.40% register free of charge .
	A rating was issued by 2 analysts: 2 Analysts recommend Vivoryon Therapeutics to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Vivoryon Therapeutics stock has an average upside potential 2026 of 275.84% register free of charge . Most analysts recommend the Vivoryon Therapeutics stock at Purchase.

Current Vivoryon Therapeutics Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
RX SECURITIES	Locked ➜ Locked	Locked	Feb 18 2025
WARBURG RESEARCH GMBH	Locked ➜ Locked	Locked	Feb 18 2025
JEFFERIES	Locked ➜ Locked	Locked	Jan 07 2025
RX SECURITIES	Locked ➜ Locked	Locked	Jan 05 2025

Analyst Rating	Date
Locked RX SECURITIES: Locked ➜ Locked	Feb 18 2025
Locked WARBURG RESEARCH GMBH: Locked ➜ Locked	Feb 18 2025
Locked JEFFERIES: Locked ➜ Locked	Jan 07 2025
Locked RX SECURITIES: Locked ➜ Locked	Jan 05 2025

Discover more stocks with a high price target

BioNTech SE - ADR 32.27%

Alibaba Group Holding Ltd 28.43%

Tencent Holdings Ltd. 22.81%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now

The Apple stock at a glance with charts, current key metrics, news and stock analyses.

The Best Dividend Stocks in the Dividend Top Scorer list.

Stock Analyses of the Best Stocks Worldwide.

Start building wealth today